Rapid Resolution ofMycobacterium marinumChronic Skin Infection during Lenalidomide Therapy for Chronic Lymphocytic Leukemia | Zendy

Ahmed Awais | Zendy; Constantine S. Tam | Zendy; Dimitrios P. Kontoyiannis | Zendy; Alessandra Ferrajoli | Zendy; Madeleine Duvic | Zendy; Jorge E. Cortés | Zendy; Michael J. Keating | Zendy

Open Access

Rapid Resolution ofMycobacterium marinumChronic Skin Infection during Lenalidomide Therapy for Chronic Lymphocytic Leukemia

Author(s) -

Ahmed Awais,

Constantine S. Tam,

Dimitrios P. Kontoyiannis,

Alessandra Ferrajoli,

Madeleine Duvic,

Jorge E. Cortés,

Michael J. Keating

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/529388

Subject(s) - lenalidomide , chronic lymphocytic leukemia , medicine , mycobacterium marinum , immunology , leukemia , immune system , multiple myeloma , mycobacterium , pathology , tuberculosis

The immunomodulatory drug lenalidomide is currently being evaluated for its antineoplastic properties in treating hematologic malignancies. However, its potential role in augmenting immune reactions against opportunistic infections has not been explored. We report the rapid resolution of chronic Mycobacterium marinum infection in a patient following initiation of lenalidomide therapy for chronic lymphocytic leukemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research